JP2023526248A5 - - Google Patents
Info
- Publication number
- JP2023526248A5 JP2023526248A5 JP2022568794A JP2022568794A JP2023526248A5 JP 2023526248 A5 JP2023526248 A5 JP 2023526248A5 JP 2022568794 A JP2022568794 A JP 2022568794A JP 2022568794 A JP2022568794 A JP 2022568794A JP 2023526248 A5 JP2023526248 A5 JP 2023526248A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024218934A JP7715911B2 (ja) | 2020-05-13 | 2024-12-13 | 神経筋疾患の処置のためのピリダジノン化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063024439P | 2020-05-13 | 2020-05-13 | |
| US63/024,439 | 2020-05-13 | ||
| PCT/US2021/031979 WO2021231565A1 (en) | 2020-05-13 | 2021-05-12 | Pyridazinone compounds for the treatment of neuromuscular diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024218934A Division JP7715911B2 (ja) | 2020-05-13 | 2024-12-13 | 神経筋疾患の処置のためのピリダジノン化合物 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023526248A JP2023526248A (ja) | 2023-06-21 |
| JPWO2021231565A5 JPWO2021231565A5 (https=) | 2024-05-22 |
| JP2023526248A5 true JP2023526248A5 (https=) | 2024-05-22 |
| JP7606537B2 JP7606537B2 (ja) | 2024-12-25 |
Family
ID=76284178
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568794A Active JP7606537B2 (ja) | 2020-05-13 | 2021-05-12 | 神経筋疾患の処置のためのピリダジノン化合物 |
| JP2024218934A Active JP7715911B2 (ja) | 2020-05-13 | 2024-12-13 | 神経筋疾患の処置のためのピリダジノン化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024218934A Active JP7715911B2 (ja) | 2020-05-13 | 2024-12-13 | 神経筋疾患の処置のためのピリダジノン化合物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230159513A1 (https=) |
| EP (2) | EP4473968A3 (https=) |
| JP (2) | JP7606537B2 (https=) |
| WO (1) | WO2021231565A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3877376T3 (da) | 2018-11-06 | 2023-10-02 | Edgewise Therapeutics Inc | Pyridazinonforbindelser og anvendelser deraf |
| CA3118908A1 (en) | 2018-11-06 | 2020-05-14 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| AU2019374812B2 (en) | 2018-11-06 | 2025-03-06 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| EP4433473A1 (en) * | 2021-11-17 | 2024-09-25 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| KR20240156632A (ko) * | 2022-04-15 | 2024-10-30 | 우한 휴먼웰 이노베이티브 드러그 리서치 앤드 디벨롭먼트 센터 리미티드 컴퍼니 | Kif18a 억제제 및 이의 용도 |
| CN121194963A (zh) | 2023-03-27 | 2025-12-23 | 艾知怀斯治疗学公司 | 喹啉酮酰胺类化合物及其用途 |
| WO2024206345A1 (en) | 2023-03-27 | 2024-10-03 | Edgewise Therapeutics, Inc. | Quinazoline dione compounds and uses thereof |
| WO2025207665A1 (en) * | 2024-03-26 | 2025-10-02 | Edgewise Therapeutics, Inc. | Quinolinone compounds and uses thereof |
| WO2025207622A1 (en) * | 2024-03-26 | 2025-10-02 | Edgewise Therapeutics, Inc. | Quinolinone, benzoxazinone, and quinoline compounds and uses thereof |
| WO2025207679A1 (en) * | 2024-03-26 | 2025-10-02 | Edgewise Therapeutics, Inc. | Quinazoline dione compounds and uses thereof |
| WO2025207677A1 (en) * | 2024-03-26 | 2025-10-02 | Edgewise Therapeutics, Inc. | Quinazolinone compounds and uses thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5376667A (en) * | 1992-12-31 | 1994-12-27 | Entropin, Inc. | Derivatives of benzoylecgonine, ecgonine and their multiple pharmacological properties |
| CN1087725C (zh) | 1994-03-25 | 2002-07-17 | 同位素技术有限公司 | 用氘代方法增强药物效果 |
| US6334997B1 (en) | 1994-03-25 | 2002-01-01 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
| AR081331A1 (es) * | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
| US8759380B2 (en) * | 2011-04-22 | 2014-06-24 | Cytokinetics, Inc. | Certain heterocycles, compositions thereof, and methods for their use |
| WO2018081378A1 (en) | 2016-10-26 | 2018-05-03 | Proteostasis Therapeutics, Inc. | Compounds, compositions, and methods for modulating cftr |
| EP3600322A1 (en) * | 2017-03-28 | 2020-02-05 | Boehringer Ingelheim International GmbH | Nintedanib for use in methods for the treatment of muscular dystrophy |
| EP3700516B1 (en) * | 2017-10-27 | 2024-01-24 | Sonic Master Limited | Inhibitors of dux4 induction for regulation of muscle function |
| DK3877376T3 (da) * | 2018-11-06 | 2023-10-02 | Edgewise Therapeutics Inc | Pyridazinonforbindelser og anvendelser deraf |
| CA3118908A1 (en) * | 2018-11-06 | 2020-05-14 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| AU2019374812B2 (en) * | 2018-11-06 | 2025-03-06 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| EP4433473A1 (en) * | 2021-11-17 | 2024-09-25 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
-
2021
- 2021-05-12 WO PCT/US2021/031979 patent/WO2021231565A1/en not_active Ceased
- 2021-05-12 EP EP24207354.2A patent/EP4473968A3/en active Pending
- 2021-05-12 EP EP21730365.0A patent/EP4149620B1/en active Active
- 2021-05-12 JP JP2022568794A patent/JP7606537B2/ja active Active
-
2022
- 2022-11-07 US US18/053,318 patent/US20230159513A1/en active Pending
-
2024
- 2024-12-13 JP JP2024218934A patent/JP7715911B2/ja active Active